Page last updated: 2024-08-05 11:38:59
beta-D-arabinoside
null
ChEBI ID: 38315
Members (4)
| Member | Definition | Role |
|---|---|---|
| 9-arabinofuranosylguanine | A purine nucleoside in which guanine is attached to arabinofuranose via a beta-N(9)-glycosidic bond. It inhibits DNA synthesis and causes cell death. | 9-beta-D-arabinofuranosylguanine |
| cytarabine | A pyrimidine nucleoside in which cytosine is attached to D-arabinofuranose via a beta-N(1)-glycosidic bond. Used mainly in the treatment of leukaemia, especially acute non-lymphoblastic leukaemia, cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. It also has antiviral and immunosuppressant properties. | cytarabine |
| nelarabine | A purine nucleoside in which O-methylguanine is attached to arabinofuranose via a beta-N(9)-glycosidic bond. Inhibits DNA synthesis and causes cell death; a prodrug of 9-beta-D-arabinofuranosylguanine (ara-G). | nelarabine |
| vidarabine | A purine nucleoside in which adenine is attached to arabinofuranose via a beta-N(9)-glycosidic bond. | adenine arabinoside |
Research
Studies (19,197)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6,599 (34.38) | 18.7374 |
| 1990's | 3,570 (18.60) | 18.2507 |
| 2000's | 3,955 (20.60) | 29.6817 |
| 2010's | 3,933 (20.49) | 24.3611 |
| 2020's | 1,140 (5.94) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 3,416 (16.54%) | 5.53% |
| Reviews | 1,615 (7.82%) | 6.00% |
| Case Studies | 2,964 (14.35%) | 4.05% |
| Observational | 44 (0.21%) | 0.25% |
| Other | 12,619 (61.09%) | 84.16% |